Perioral dermatitis
☆ AI Dermatology — Free Service
Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
A na-ahụkarị papules n'akụkụ ọnụ na imi, nke nwere ụfọdụ ọbara n'azụ, dị ka patch ma ọ bụ pustule n'akụkụ ọnụ.
relevance score : -100.0%
ReferencesPerioral dermatitis bụ ọnọdụ akpụkpọ ahụ na-adịghị mma nke a na-ahụkarị n’ụmụ agbọghọ, nke na-egosipụta site n’akpụkpọ anụ pere mpe, na-acha uhie uhie ma ọ bụ akpụkpọ anụ kpọrọ nkụ n’akụkụ ọnụ. Ọ bụ ezie na ọ na-emetụkarị mpaghara a, ọ pụkwara apụta n’akụkụ anya na imi, nke na-eduga n’aha ya ọzọ, periorificial dermatitis. Ojiji nke steroid n’elu ihu nwere ike ịkpalite ọnọdụ a; ya mere, nzọụkwụ mbụ n’ịgwọ ya bụ ịkwụsị iji steroid ndị a. Nhọrọ ọgwụgwọ ndị ọzọ gụnyere itinye metronidazole n’elu ma ọ bụ calcineurin inhibitors, ma ọ bụ ịṅụ ọgwụ nje tetracycline n’ọnụ. Perioral dermatitis na-anabata ọgwụgwọ nke ọma, mana ọ nwere ike ịdịgide mgbe ụfọdụ ma ọ bụ na-alọghachi ugboro ugboro.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Propolis bụ ihe lipophilic nke a na-amịpụta n'osisi site na aṅụ. Ebumnuche nke akụkọ ikpe a bụ igosi mkpa ihe a dị ka ihe kpatara nfụkasị kọntaktị cheilitis. Otu nwanyị dị afọ 21 nwere ọrịa na-enwe mkpesa pruritic perioral eczema kemgbe afọ ise. N'ime ọnwa gara aga, ọ na-emetụtakwa olu. Mgbe a chọpụtara na ọ nwere kọntaktị dermatitis, e debere ya n'ule patch. Nsonaazụ ule patch gosiri mmeghachi omume siri ike maka propolis (++).
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
E nwere ọtụtụ ọrịa akpụkpọ anụ nke na-eme ka papules na-acha uhie uhie pụta. Ụfọdụ n’ime ha bụ ọrịa ndị a na-ahụkarị n’ụlọ ọgwụ: folliculitis, rosacea. Ụfọdụ ndị ọzọ bụ ọrịa na-adịghị ahụkebe: eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), lupus miliaris disseminatus faciei (LMDF).
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Steroid a na-etinye n'ahụ nwere ike ịbụ ihe kpatara ọnọdụ a, yana iji ihe ịchọ mma nwere ike ime ka ọ na‑eto. Ọgwụgwọ na-abụkarị site n'ịkwụsị steroid na ihe ịchọ mma; n'ọnọdụ ndị ka njọ, a na‑ewe tetracyclines n'ọnụ. Ịkwụsị steroid nwere ike ime ka mgbu na‑aka njọ n'oge mbụ.
A na‑echere na ọnọdụ a metụtara 0.5‑1 % nke ndị mmadụ kwa afọ n’ọtụtụ mba mepere emepe. Ihe ruru 90 % nke ndị metụtara ya bụ ụmụ nwanyị nọ n’agbata afọ 16 na 45.
○ Ọgwụgwọ ― OTC Ọgwụ
A na‑ebute perioral dermatitis site na kọntaktị dermatitis nke ihe ịchọ mma, ya mere a naghị atụ aro itinye ihe ịchọ mma n'akụkụ ọnụ. Inweta OTC antihistamine nwere ike inye aka. Ọgwụgwọ nwere ike were ọtụtụ ọnwa.
#OTC antihistamine